Former Google head to lead comms for M3

March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3
Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
NICE approves Velcade
March 21, 2014Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma
NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …
IBM supercomputer could hold key to brain cancer
March 21, 2014Medical Communications, Sales and Marketing avastin, brain cancer, ibm, nygc, supercomputer
The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …
Amgen names senior VP of Business Development
March 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad
Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …
EMA launches speedy pilot
March 21, 2014Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials
The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …
AstraZeneca banks on MasterCard for director
March 20, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard
AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …
AstraZeneca signs Vodafone contract
March 20, 2014Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone
AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …
GSK cancer vaccine fails again
March 20, 2014Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma
GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials. The …
BIA welcomes budget statement
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme
An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …
Takeda hires head of emerging markets
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford
Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …
FDA ‘not trusted’ by Americans
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, JAMA, MMR, US, america, conspiracy, yougov
More than one-third of Americans in a new survey think the Food and Drug Administration is holding back new cures …
Allergan reprimanded over Botox promotion
March 19, 2014Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel
Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …
Merck Serono appoints head of strategy from Roche
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meeta Gulyani, Merck Serono, Roche
Merck Serono the German biopharma division of Merck has appointed Meeta Gulyani to the position of head of strategy and …
Europe: TB treatment ‘far below’ target
March 19, 2014Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis
European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …
Success for Amgen’s ‘bad’ cholesterol injection
March 18, 2014Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla
An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …
BMS hopes for Yervoy sequel with new deal
March 18, 2014Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology
Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …
Pfizer sues over Viagra generic
March 18, 2014Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra
Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …
Patheon completes $2.65 billion merger with DSM
March 18, 2014Manufacturing and Production, Sales and Marketing CDMO, DSM, Patheon, dpx, manufacturing
The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx. The …
IDEA Pharma appoints vice president
March 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IDEA Pharma, Jacquelyn Nicholson
Biopharma firm IDEA Pharma has appointed Jacquelyn Nicholson as vice president to head up its west coast US operations. Nicholson …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
